Epigenetic landscape of amphetamine and methamphetamine addiction in rodents
- PMID: 26023847
- PMCID: PMC4622560
- DOI: 10.1080/15592294.2015.1055441
Epigenetic landscape of amphetamine and methamphetamine addiction in rodents
Abstract
Amphetamine and methamphetamine addiction is described by specific behavioral alterations, suggesting long-lasting changes in gene and protein expression within specific brain subregions involved in the reward circuitry. Given the persistence of the addiction phenotype at both behavioral and transcriptional levels, several studies have been conducted to elucidate the epigenetic landscape associated with persistent effects of drug use on the mammalian brain. This review discusses recent advances in our comprehension of epigenetic mechanisms underlying amphetamine- or methamphetamine-induced behavioral, transcriptional, and synaptic plasticity. Accumulating evidence demonstrated that drug exposure induces major epigenetic modifications-histone acetylation and methylation, DNA methylation-in a very complex manner. In rare instances, however, the regulation of a specific target gene can be correlated to both epigenetic alterations and behavioral abnormalities. Work is now needed to clarify and validate an epigenetic model of addiction to amphetamines. Investigations that include genome-wide approaches will accelerate the speed of discovery in the field of addiction.
Keywords: AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMPH, amphetamine; AP1, activator protein 1; ATF2, activating transcription factor 2; BASP1, brain abundant signal protein 1; BDNF, brain derived neurotrophic factor; CCR2, C‒C chemokine receptor 2; CPP, conditioned place preference; CREB, cAMP response element binding protein; ChIP, chromatin immunoprecipitation; CoREST, restrictive element 1 silencing transcription factor corepressor; Cp60, compound 60; DNA methylation; DNMT, DNA methyltransferase; FOS, Finkel–Biskis–Jinkins murine osteosarcoma viral oncogene; GABA, γ-aminobutyric acid; GLUA1, glutamate receptor subunit A1; GLUA2, glutamate receptor subunit A2; GLUN1, glutamate receptor subunit N1; H2Bac, pan-acetylation of histone 2B; H3, histone 3; H3K14Ac, acetylation of histone 3 at lysine 14; H3K18, lysine 18 of histone 3; H3K4, lysine 4 of histone 3; H3K4me3, trimethylation of histone 3 at lysine 4; H3K9, lysine 9 of histone 3; H3K9Ac, acetylation of histone 3 at lysine 9; H3K9me3, trimethylation of histone 3 at lysine 9; H4, histone 4; H4Ac, pan-acetylation of histone 4; H4K12Ac, acetylation of histone 4 at lysine 12; H4K16, lysine 16 of histone 4; H4K5, lysine 5 of histone 4; H4K8, lysine 8 of histone 4; HAT, histone acetyltransferase; HDAC, histone deacetylase; HDM, histone demethylase; HMT, histone methyltransferase; IP, intra-peritoneal; JUN, jun proto-oncogene; KDM, lysine demethylase; KLF10, Kruppel-like factor 10; KMT, lysine methyltransferase; METH, methamphetamine; MeCP2, methyl-CpG binding protein 2; NAc, nucleus accumbens; NMDA, N-methyl-D-aspartate; NaB, sodium butyrate; OfC, orbitofrontal cortex; PfC, prefrontal cortex; REST, restrictive element 1 silencing transcription factor; RNAi, RNA interference; Ser241, serine 241; Sin3A, SIN3 transcription regulator family member A; TSS, transcription start site; VPA, valproic acid; WT1, Wilms tumor protein 1.; amphetamine; histone acetylation; histone methylation; methamphetamine; siRNA, silencing RNA.
Figures
Similar articles
-
Methamphetamine downregulates striatal glutamate receptors via diverse epigenetic mechanisms.Biol Psychiatry. 2014 Jul 1;76(1):47-56. doi: 10.1016/j.biopsych.2013.09.034. Epub 2013 Oct 16. Biol Psychiatry. 2014. PMID: 24239129 Free PMC article.
-
Methamphetamine causes differential alterations in gene expression and patterns of histone acetylation/hypoacetylation in the rat nucleus accumbens.PLoS One. 2012;7(3):e34236. doi: 10.1371/journal.pone.0034236. Epub 2012 Mar 28. PLoS One. 2012. PMID: 22470541 Free PMC article.
-
The effects of single-dose injections of modafinil and methamphetamine on epigenetic and functional markers in the mouse medial prefrontal cortex: potential role of dopamine receptors.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jan 10;88:222-234. doi: 10.1016/j.pnpbp.2018.07.019. Epub 2018 Jul 26. Prog Neuropsychopharmacol Biol Psychiatry. 2019. PMID: 30056065 Free PMC article.
-
[Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target].Biol Aujourdhui. 2017;211(1):83-91. doi: 10.1051/jbio/2017014. Epub 2017 Jul 6. Biol Aujourdhui. 2017. PMID: 28682229 Review. French.
-
Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?Pharmacol Ther. 2013 Oct;140(1):34-52. doi: 10.1016/j.pharmthera.2013.05.010. Epub 2013 May 24. Pharmacol Ther. 2013. PMID: 23711791 Review.
Cited by
-
Epigenome-wide association study on methamphetamine dependence.Addict Biol. 2024 Mar;29(3):e13383. doi: 10.1111/adb.13383. Addict Biol. 2024. PMID: 38488760 Free PMC article.
-
Variations in the oral microbiome and metabolome of methamphetamine users.mSystems. 2024 Jan 23;9(1):e0099123. doi: 10.1128/msystems.00991-23. Epub 2023 Dec 19. mSystems. 2024. PMID: 38112416 Free PMC article.
-
METH exposure alters sperm DNA methylation in F0 mice and mPFC transcriptome in male F1 mice.Psychopharmacology (Berl). 2024 May;241(5):897-911. doi: 10.1007/s00213-023-06516-2. Epub 2023 Dec 13. Psychopharmacology (Berl). 2024. PMID: 38092953
-
Exploring new histone deacetylase 6 inhibitors and their effects on reversing the α-tubulin deacetylation and cell morphology changes caused by methamphetamine.Arch Pharm Res. 2023 Oct;46(9-10):795-807. doi: 10.1007/s12272-023-01467-w. Epub 2023 Sep 30. Arch Pharm Res. 2023. PMID: 37777709
-
Methamphetamine-induced region-specific transcriptomic and epigenetic changes in the brain of male rats.Commun Biol. 2023 Sep 27;6(1):991. doi: 10.1038/s42003-023-05355-3. Commun Biol. 2023. PMID: 37758941 Free PMC article.
References
-
- Howell LL, Kimmel HL. Monoamine transporters and psychostimulant addiction. Biochem Pharmacol 2008; 75:196-217; PMID:17825265; http://dx.doi.org/10.1016/j.bcp.2007.08.003 - DOI - PubMed
-
- Schultz W. Multiple reward signals in the brain. Nat Rev Neurosci 2000; 1:199-207; PMID:11257908; http://dx.doi.org/10.1038/35044563 - DOI - PubMed
-
- Goodwin JS, Larson GA, Swant J, Sen N, Javitch JA, Zahniser NR, Felice LJD, Khoshbouei H. Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo. J Biol Chem 2009; 284:2978-89; PMID:19047053; http://dx.doi.org/10.1074/jbc.M805298200 - DOI - PMC - PubMed
-
- Cadet JL, Krasnova IN, Jayanthi S, Lyles J. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox Res 2007; 11:183-202; PMID:17449459; http://dx.doi.org/10.1007/BF03033567 - DOI - PubMed
-
- Bird A. Perceptions of epigenetics. Nature 2007; 447:396-8; PMID:17522671; http://dx.doi.org/10.1038/nature05913 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous